Brief: Lavipharm Q3 EBITDA Down To EUR 1.5 Million
22/11/2022 16:13
Nov 22 (Reuters) - Lavipharm SA LPHr.AT :
* Q3 SALES EUR 12.0 MILLION VERSUS EUR 8.9 MILLION YEAR AGO
* Q3 EBITDA EUR 1.5 MILLION VERSUS EUR 1.7 MILLION YEAR AGO
Further company coverage: LPHr.AT
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Lavipharm SA
See all newsBrief: Lavipharm Q1 Earnings Before Tax From Continuing Operations €1.41 Million, Up 28.6% YoY
Brief: Lavipharm To Acquire Durogesic Pain Patch Rights From Janssen For $12.0 Million
Brief: Lavipharm SA FY 2025 Earnings After Tax EUR 6.0 Million Versus EUR 9.0 Million Year Ago
Brief: Lavipharm 9-Month Net Profit Down To EUR 3.5 Million
Brief: Lavipharm H1 Adjusted EBITDA At EUR 7.7 Million, Up 29.4% YoY